Article(id=1326651826734216000, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.12.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1744041600000, receivedDateStr=2025-04-08, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228043453, onlineDateStr=2026-11-09, pubDate=1765296000000, pubDateStr=2025-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228043453, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228043453, creator=13701087609, updateTime=1794228043453, updator=13701087609, issue=Issue{id=1326651677442159392, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='12', pageStart='1201', pageEnd='1311', issueExtLink='null', onlineDate='null', pubDate='1765296000000', pubDateStr='2025-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228007890, creator='13701087609', updateTime=1794272794012, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326839524379964187, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326839524379964188, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1290, endPage=1297, ext={EN=ArticleExt(id=1326651827065566017, articleId=1326651826734216000, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=The clinical efficacy of tislelizumab combined with Nab-PP in the treatment of advanced lung squamous cell carcinoma with high PD-L1 expression, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective To explore the clinical study of tislelizumab combined with nab-paclitaxel and cisplatin(Nab-PP) for advanced lung squamous cell carcinoma with high expression of programmed death-ligand(PD-L)1.
Methods The clinical data of patients with advanced lung squamous cell carcinoma with high PD-L1 expression who were admitted to our hospital from November 2020 to June 2023 were retrospectively collected. A total of 99 patients who received Nab-PP combined with tislelizumab treatment(the monoclonal antibody group), and 91 patients who received only Nab-PP treatment during the same period(the reference group) were initially included. The propensity score matching method was adopted, and the matching was carried out according to the 1∶1 ratio principle. Eventually, 52 patients in each group were successfully matched. The clinical efficacy, immune indicators, tumor markers, degree of primary lesion remission, functional status, quality of life scores, survival situation and safety between the two groups were compared.
Results The objective response rate of the monoclonal antibody group(55.77%) was higher than that of the reference group(32.69%, P<0.05). After treatment, the levels of CD3+, CD4+, CD4+/CD8+ and natural killer cells in the monoclonal antibody group were all higher than those in the reference group, while the levels of squamous cell carcinoma antigen, carcinoembryonic antigen, cytokeratin 19 fragment and matrix metalloproteinase 9 were all lower than those in the reference group(P<0.05). In the monoclonal antibody group, there were 18 cases in stage Ⅲb. Among them, 16 cases(88.9%) eventually underwent radical surgery. Postoperative pathology confirmed 9 cases(56.3%) of major pathological response and 7 cases(43.8%) of pathological complete response. After the treatment, the Karnofsky performance status and the systematic evaluation of pulmonary function - lung score of the monoclonal antibody group were both higher than those of the reference group(P<0.05). The median progression-free survival and overall survival in the monoclonal antibody group were significantly higher than those in the reference group(χ2=13.882, 12.323, P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).
Conclusion Tislelizumab combined with the Nab-PP regimen can significantly improve the clinical efficacy of patients with advanced lung squamous cell carcinoma with high PD-L1 expression, prolong survival time, and has a good safety profile. It is suitable for clinical promotion and application.
, authors=Meng LI, Xueqin ZHANG, Chenyang ZHAO, Yuan XING
*, authorsList=Meng LI, Xueqin ZHANG, Chenyang ZHAO, Yuan XING, authorCompany=null, correspAuthors=Yuan XING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326651827405304642, articleId=1326651826734216000, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=替雷利珠单抗联合Nab-PP治疗PD-L1高表达晚期肺鳞癌的临床疗效, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的 探讨替雷利珠单抗联合白蛋白结合型紫杉醇和顺铂(Nab-PP)治疗程序性死亡受体配体(programmed death-ligand,PD-L)1高表达晚期肺鳞癌的临床研究。
方法 回顾性收集2020年11月至2023年6月本院收治的PD-L1高表达晚期肺鳞癌患者的临床资料。初步纳入接受Nab-PP联合替雷利珠单抗治疗的患者99例(单抗组)及同期仅接受Nab-PP治疗的患者91例(参照组)。采用倾向性评分匹配方法,按照1∶1配比原则进行匹配,最终成功匹配每组52例患者。比较两组临床疗效、免疫指标、肿瘤标志物、原发病灶缓解程度、功能状态及生活质量评分以及生存情况和安全性。
结果 观察组客观缓解率(55.77%)高于参照组(32.69%)(P<0.05)。治疗后,单抗组CD3+、CD4+、CD4+/CD8+以及自然杀伤细胞水平均高于参照组,鳞状细胞癌抗原、癌胚抗原、细胞角蛋白19片段以及基质金属蛋白酶9水平均低于参照组(P<0.05)。单抗组有Ⅲb期18例,其中16例(88.9%)最终接受根治性手术,术后病理证实主要病理缓解9例(56.3%),病理完全缓解7例(43.8%)。治疗后,单抗组卡氏功能状态、肿瘤治疗功能系统评价-肺部评分均高于参照组(P<0.05)。单抗组的中位无进展生存期和总生存期均显著高于参照组(χ2=13.882、12.323,P<0.05)。两组不良反应发生率无显著差异(P>0.05)。
结论 替雷利珠单抗联合Nab-PP方案能显著提高PD-L1高表达晚期肺鳞癌患者的临床疗效,延长生存期,安全性良好,适合临床推广应用。
, authors=李萌, 张学琴, 赵晨阳, 邢源
*, authorsList=李萌, 张学琴, 赵晨阳, 邢源, authorCompany=null, correspAuthors=邢源, authorNote=
, correspAuthorsNote=
邢源,药师,研究方向:肿瘤药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=kjVaTZgVsN8q/XS0hbrzyA==, magXml=noCX87V9iNTRnUi0RuAWYw==, pdfUrl=null, pdf=KVzMiwz/yOobnIkvnMq+dA==, pdfFileSize=1835379, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=m3hIejAFSBbyu8n9D14Ixg==, mapNumber=null, fund=null)}, authors=[Author(id=1326651827761820487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651827862483785, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651827761820487, language=EN, stringName=Meng LI, firstName=Meng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651827975729994, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651827761820487, language=CN, stringName=李萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000, bio={"content":"
李萌,药师,研究方向:静脉用药。
"}, bioImg=null, bioContent=
李萌,药师,研究方向:静脉用药。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651827686323011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, xref=null, ext=[AuthorCompanyExt(id=1326651827694711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China), AuthorCompanyExt(id=1326651827703100229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000)])]), Author(id=1326651828042838860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651828135113550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828042838860, language=EN, stringName=Xueqin ZHANG, firstName=Xueqin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651828206416719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828042838860, language=CN, stringName=张学琴, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651827686323011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, xref=null, ext=[AuthorCompanyExt(id=1326651827694711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China), AuthorCompanyExt(id=1326651827703100229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000)])]), Author(id=1326651828302885713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651828403549011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828302885713, language=EN, stringName=Chenyang ZHAO, firstName=Chenyang, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651828470657876, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828302885713, language=CN, stringName=赵晨阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651827686323011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, xref=null, ext=[AuthorCompanyExt(id=1326651827694711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China), AuthorCompanyExt(id=1326651827703100229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000)])]), Author(id=1326651828596486998, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326651828688761688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828596486998, language=EN, stringName=Yuan XING, firstName=Yuan, middleName=null, lastName=XING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651828848145241, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, authorId=1326651828596486998, language=CN, stringName=邢源, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651827686323011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, xref=null, ext=[AuthorCompanyExt(id=1326651827694711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China), AuthorCompanyExt(id=1326651827703100229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000)])])], keywords=[Keyword(id=1326651828990751578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=1, keyword=tislelizumab), Keyword(id=1326651830664278875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=2, keyword=paclitaxel), Keyword(id=1326651830756553564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=3, keyword=cisplatin), Keyword(id=1326651830836245341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=4, keyword=lung squamous cell carcinoma), Keyword(id=1326651830924325726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=5, keyword=clinical efficacy), Keyword(id=1326651830983045983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=EN, orderNo=6, keyword=safety), Keyword(id=1326651831066932064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=1, keyword=替雷利珠单抗), Keyword(id=1326651831125652321, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=2, keyword=紫杉醇), Keyword(id=1326651831184372578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=3, keyword=顺铂), Keyword(id=1326651831251481443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=4, keyword=肺鳞癌), Keyword(id=1326651831318590308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=5, keyword=临床疗效), Keyword(id=1326651831427642213, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, language=CN, orderNo=6, keyword=安全性)], refs=[Reference(id=1326651831813518184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=朱玉斐, 黄智昊, 蔡依辰, 等. 替雷利珠单抗联合化疗对比帕博利珠单抗联合化疗一线治疗晚期肺鳞癌患者的疗效[J]. 实用医学杂志, 2025, 41(7): 1024-1029., articleTitle=null, refAbstract=null), Reference(id=1326651831905792873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=柏宇舜, 郑吉, 李竞饶, 等. 补体激活通路基因遗传变异与非小细胞肺癌患者生存的相关性及其分子机制探讨[J].现代肿瘤医学, 2022, 30(15): 2739-2743., articleTitle=null, refAbstract=null), Reference(id=1326651832027427690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=高鸣, 周清. 晚期肺鳞癌治疗进展[J]. 中国肺癌杂志, 2020,23(10): 866-874., articleTitle=null, refAbstract=null), Reference(id=1326651832111313771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=刘爽, 刘倩, 庞茜茜, 等. 替雷利珠单抗联合化疗治疗Ⅲb~Ⅳ期非小细胞肺癌的效果[J]. 实用医院临床杂志, 2024,21(3): 112-116., articleTitle=null, refAbstract=null), Reference(id=1326651832182616940, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=牛素梅, 张驰, 马燕, 等. 马来酸阿法替尼片联合顺铂加紫杉醇治疗晚期非小细胞肺癌的效果研究[J]. 中国医药,2024, 19(8): 1160-1163., articleTitle=null, refAbstract=null), Reference(id=1326651832304251757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社.中华医学会肺癌临床诊疗指南(2018版)[J]. 中华肿瘤杂志, 2018, 40(12): 935-964., articleTitle=null, refAbstract=null), Reference(id=1326651832413303662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=薛卫成. 介绍乳腺癌TNM分期系统(第7版)[J]. 诊断病理学杂志, 2010, 17(4): 241-244., articleTitle=null, refAbstract=null), Reference(id=1326651832488801136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ISHIDA Y, KAMIBEPPU K, SATO A,
et al. Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood[J]. Int J Hematol, 2022, 116(5):787-797., articleTitle=null, refAbstract=null), Reference(id=1326651832715293553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=EISENHAUER EA, THERASSE P, BOGAERTS J,
et al.New response evaluation criteria in solid tumours: revised RECIST guideline(version 1.1)[J]. Eur J Cancer, 2009,45(2): 228-247., articleTitle=null, refAbstract=null), Reference(id=1326651832803373938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=国家肿瘤质控中心肺癌质控专家委员会. 非小细胞肺癌新辅助治疗疗效病理评估专家共识[J]. 中华病理学杂志,2021, 50(9): 1002-1007., articleTitle=null, refAbstract=null), Reference(id=1326651832925008755, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TEMEL JS, GREER JA, MUZIKANSKY A,
et al. Early palliative care for patients with metastatic non-small-cell lung cancer[J]. N Engl J Med, 2010, 363(8): 733-742., articleTitle=null, refAbstract=null), Reference(id=1326651833084392308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI L, MENG Q, TONG L,
et al. Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell lung cancer[J]. Front Oncol, 2022, 12: 956755., articleTitle=null, refAbstract=null), Reference(id=1326651833256358773, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHMULTS CD, BLITZBLAU R, AASI SZ,
et al. NCCN guidelines insights: merkel cell carcinoma, version 1.2024[J].J Natl Compr Canc Netw, 2024, 22(1D): e240002., articleTitle=null, refAbstract=null), Reference(id=1326651833403159414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=王家乐, 邱天羽, 崔亚男, 等. 2024 CSCO非小细胞肺癌指南(晚期部分)解读[J]. 同济大学学报(医学版), 2024, 45(4):465-470., articleTitle=null, refAbstract=null), Reference(id=1326651835072492408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG J, LU S, YU X,
et al. Tislelizumab plus chemotherapy vs chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: a phase 3 randomized clinical trial[J]. J Am Med Assoc Oncol, 2021, 7(5): 709-717., articleTitle=null, refAbstract=null), Reference(id=1326651835185738617, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG P, MAO Z, WANG Q,
et al. An indirect comparison between nivolumab+ipilimumab+two cycles of chemo-therapy vs. pembrolizumab+chemotherapy as first-line treatment for metastatic non-small cell lung cancer[J]. Front Oncol, 2021, 11: 698199., articleTitle=null, refAbstract=null), Reference(id=1326651835269624698, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GADGEEL SM, RODRÍGUEZ-ABREU D, HALMOS B,
et al. Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score less than 1%: pooled analysis of outcomes after five years of follow-up[J]. J Thorac Oncol, 2024, 19(8): 1228-1241., articleTitle=null, refAbstract=null), Reference(id=1326651835349316475, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Y, HE J, ZHOU S,
et al. The effect of PD‐1 inhibitor combined with chemotherapy on the level of peripheral blood T lymphocytes among patients with non‐small‐cell lung cancer and its relationship with prognosis[J]. Comput Math Methods Med, 2022, 2022(1): 1679191., articleTitle=null, refAbstract=null), Reference(id=1326651835454174076, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, GU T, TIAN X,
et al. A small molecule antagonist of PD-1/PD-L1 interactions acts as an immune checkpoint inhibitor for NSCLC and melanoma immunotherapy[J].Front immunol, 2021, 12: 654463., articleTitle=null, refAbstract=null), Reference(id=1326651835529671549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=谢康, 蔡永广. 基于PD-1/PD-L1探究替雷利珠单抗对紫杉醇联合铂类一线治疗中晚期肺鳞癌的协同增效作用[J].肿瘤药学, 2024, 14(4): 457-462., articleTitle=null, refAbstract=null), Reference(id=1326651835592586110, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=梁超, 李浩, 韩大千, 等. 支气管动脉灌注化疗栓塞联合替雷利珠单抗治疗晚期非小细胞肺癌的有效性与安全性[J].介入放射学杂志, 2025, 34(2): 148-153., articleTitle=null, refAbstract=null), Reference(id=1326651835663889279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=邱学佳, 张玥, 连玉菲, 等. PD-1/PD-L1抑制剂在新辅助化疗中的应用进展[J]. 中国新药杂志, 2020, 29(9): 1007-1011., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326651831649940326, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, awardId=20241481, language=CN, fundingSource=河北省2024年度医学科学研究计划项目(20241481), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326651827686323011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, xref=null, ext=[AuthorCompanyExt(id=1326651827694711620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Intravenous Drug Dispensing Center, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China), AuthorCompanyExt(id=1326651827703100229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651826734216000, companyId=1326651827686323011, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北北方学院附属第一医院药学部静脉用药调配中心,河北 张家口 075000)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.12.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.12.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.12.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.12.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1765296000000, fullTextJson=null, articleText=null, reference=null)